Hostname: page-component-6b88cc9666-cdmm5 Total loading time: 0 Render date: 2026-02-17T20:15:23.737Z Has data issue: false hasContentIssue false

Qualitative evaluation of a statewide antibiotic stewardship quality improvement sepsis intervention

Published online by Cambridge University Press:  12 February 2026

Sara M. Karaba*
Affiliation:
The Johns Hopkins University School of Medicine, USA
Kathryn Dzintars
Affiliation:
Johns Hopkins Hospital, USA
Priyanka J. Desai
Affiliation:
NORC: National Opinion Research Center, USA
Rachel T. Kurtzman
Affiliation:
NORC: National Opinion Research Center, USA
Mary Clance
Affiliation:
Luminis Health, USA
Leigh Smith
Affiliation:
University of Maryland School of Medicine, USA
Lindsay Abdulhay
Affiliation:
NORC: National Opinion Research Center, USA
Rebecca Perlmutter
Affiliation:
Maryland Department of Health, USA
Margaret Byrne
Affiliation:
NORC: National Opinion Research Center, USA
Surbhi Leekha
Affiliation:
University of Maryland School of Medicine, USA
Kimberly C. Claeys
Affiliation:
University of Maryland School of Pharmacy, USA
Megan Dunning
Affiliation:
University of Maryland School of Medicine, USA
Prashila Dullabh
Affiliation:
NORC: National Opinion Research Center, USA
Sara E. Cosgrove
Affiliation:
The Johns Hopkins University School of Medicine, USA
Emily Heil
Affiliation:
University of Maryland School of Pharmacy, USA
Jacqueline T. Bork
Affiliation:
University of Maryland School of Medicine, USA
*
Corresponding author: Sara Karaba; Email: sara.karaba@jhmi.edu

Abstract

Objective:

From 2023–2024, the Maryland Statewide Prevention & Reduction Collaborative (SPARC) led an intervention targeting broad-spectrum antibiotic use for sepsis, aiming to identify the factors that influence the success of collaborative quality improvement (QI) programs.

Design:

Evaluation of a state collaborative run QI intervention.

Participants:

Acute-care facilities in Maryland.

Methods:

Participating sites developed and implemented sepsis-focused interventions with SPARC support, including tailored guidance and bimonthly office hours. Following the implementation of site-level interventions, sites participated in a mixed-methods assessment guided by the RE-AIM framework including brief qualitative interviews and a 6-month follow-up.

Results:

Eight hospitals implemented multi-component, multi-disciplinary sepsis-focused interventions. Facilities involved staff from up to six departments in the implementation of interventions. All sites noted the effectiveness of SPARC in supporting sites’ intervention activities, as well as the effectiveness of the site’s interventions in creating change. Sites identified barriers impacting the implementation of their interventions including lack of resources, administrative red-tape, and challenges changing culture. Facilitators included leadership support, having a structured intervention plan, and opportunities for peer-to-peer learning. Most sites were positive about SPARC’s role identifying interventions and support, utilized information from SPARC as part of their interventions, and found it useful to hear how other institutions implement antibiotic stewardship. Six months post-assessment, all sites were continuing intervention activities.

Conclusions:

This evaluation highlights how statewide QI collaboratives can be effective in promoting hospital-based antibiotic stewardship. Sites identified several facilitators and challenges that contributed to intervention implementation and highlighted the contributions of the SPARC team.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America

Introduction

Antimicrobial resistance (AMR) is a pervasive issue that can lead to difficult-to-treat infections. 1 Overuse and misuse of antimicrobials can contribute to the development of AMR and other harms resulting in poor health outcomes. 1 A significant driver of broad-spectrum antibiotic use is sepsis, a clinical syndrome with variable presentation and high mortality making early diagnosis and appropriate treatment challenging and imperative. Reference Weinberger, Rhee and Klompas2,Reference Fitzpatrick, Tarrant, Hamilton, Kiernan, Jenkins and Krockow3 To improve sepsis outcomes, several organizations recommend immediate treatment with broad-spectrum antibiotics for all suspected sepsis cases. Reference Weinberger, Rhee and Klompas2 However, recent studies show these guidelines contribute to overprescribing of broad-spectrum antibiotics, and only a fraction of these patients had true infections. Reference Rhee, Chen and Kadri4

The goals of antimicrobial stewardship and sepsis treatment often conflict, with early diagnosis reducing mortality, while broad-spectrum antibiotics use increases risk of AMR. Reference Fitzpatrick, Tarrant, Hamilton, Kiernan, Jenkins and Krockow3 Sepsis is an important target for Antibiotic Stewardship Programs (ASPs) that balance these goals to ensure patients receive timely, appropriate treatment. Hospital ASPs are instrumental in improving quality of antimicrobial prescribing and reducing AMR, 5 and using quality improvement (QI) methods help them remain relevant and effective.

The SPARC collaborative

Collaborative QI programs have been used to facilitate ASPs and address AMR. Reference Vaughn, Gupta and Petty6Reference Bhatt, Smith, Neuhauser, Srinivasan, Moore and Hyun8 The Maryland Statewide Prevention & Reduction Collaborative (SPARC) is a statewide QI project led by the Maryland Department of Health, with academic partners at University of Maryland Baltimore and Johns Hopkins University School of Medicine, and implementation contractor NORC at the University of Chicago (NORC). The SPARC team includes more than 15 Maryland healthcare providers, including physicians and pharmacists, along with representatives from the Maryland Department of Health. The SPARC team focuses on infection prevention and antibiotic stewardship and works to address evolving needs of Maryland acute care hospitals through webinars, office hours, and interventions that facilitate peer-to-peer learning. Previous SPARC interventions targeting C. difficile and COVID-19 identified collaboration, team-based approaches, peer-to-peer learning, and responsiveness to hospital needs and priorities as key implementation drivers. Reference Rock, Perlmutter and Blythe9,Reference Desai, Rock and Leekha10 In 2023, SPARC launched an intervention focused on broad-spectrum antibiotic use for sepsis, seeking to implement a targeted hospital-level intervention. To understand factors influencing success of collaborative QI programs, we conducted a mixed-method evaluation of this intervention.

Methods

Intervention development and implementation

The SPARC Sepsis Intervention was a targeted QI intervention in Maryland facilities interested in improving their antibiotic stewardship policies and practices related to sepsis. SPARC supported sites in identifying facility-specific opportunities to address broad-spectrum antibiotic use postadmission and developing tailored interventions. Facilities were recruited through a listserv of antibiotic stewardship contacts from Maryland acute care hospitals, and the opportunity was available to all facilities. Each site designed an intervention targeting broad-spectrum antibiotics prescribed for sepsis using a planning template (Appendix 1). Sites identified facility-specific opportunities for intervention, and interventions focused on both process (eg, use of order sets, improved communication) and outcome improvements (eg, reduce inappropriate use, appropriate de-escalation) customized to their needs. Intervention plans were developed following an in-person SPARC site visit and drawing on the SMART goals framework described antibiotic(s) of focus, unit, time line, intervention components, and how they would measure success. Sites were encouraged to focus on specific, reasonable and achievable interventions that focused on inpatient settings. Reference Carroll, Smith, Frazier, Weiner and Johnson11

Throughout the intervention, SPARC provided ongoing support through monthly webinars, an in-person site visit, tailored guidance, and small group office hours (Table 1). The half-day site visit was with key facility staff to discuss facility-specific antimicrobial needs related to sepsis. Sites were invited to bimonthly SPARC-facilitated office hours, and tailored support was available through email or virtual meetings with the SPARC team. Postimplementation of their interventions, sites participated in a mixed-methods assessment to assess the intervention’s impact on their stewardship efforts.

Table 1. SPARC sepsis intervention components

Intervention evaluation

Sites were recruited over several months to allow time for implementation, and interventions varied in length. Assessment activities occurred between April and August 2024 and included interviews and a six-month follow-up.

Interview guide

NORC conducted 30-min interviews using a semi-structured interview guide based on the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). Reference Holtrop, Estabrooks and Gaglio12 The guide focused on understanding (a) the status of the intervention (reach and effectiveness), (b) barriers and facilitators to implementation (adoption and implementation), and (c) next steps and areas of future support (maintenance) (Table 2). To reduce the potential for social desirability bias, the SPARC team reviewed the interview guide but did not participate in the interviews.

Table 2. Operationalization of the RE-AIM framework dimensions

Six month follow up

Six months after the interviews, NORC sent individual emails to participating facilities requesting an update on the status of their intervention.

Analysis

Interview transcripts were analyzed by NORC on an ongoing basis using a content analysis approach incorporating notes taken during interviews and audio recordings to identify emerging themes. Reference Erlingsson and Brysiewicz13 Each interview was coded by a member of the evaluation team trained in qualitative methods using a codebook deductively developed based on the interview guide. To ensure coding validity, coders independently coded two interviews and reviewed any discrepancies to reach consensus on the final coding approach. Reference O’Connor and Joffe14 Disagreements and themes were discussed as a group. Themes were organized under RE-AIM domains. Site visit notes and intervention plans were analyzed to assess reach and progress relative to initial plans. To reduce potential bias, the SPARC team did not review transcripts or participate in the coding process.

Results

Eight facilities participated in this QI intervention designing multicomponent antibiotic stewardship sepsis-focused interventions. Sites selected antibiotics commonly used for sepsis in their facilities as potential intervention targets and focused on promoting appropriate use. Table 3 presents facility and intervention characteristics for participating sites. Seven facilities were community hospitals affiliated with larger hospital systems, and one facility was independent.

Table 3. Facility and intervention characteristics

All sites participated in the intervention assessment. Interview participants included antimicrobial stewardship teams, pharmacy staff, infectious disease providers, hospital leadership, and representatives from nursing (range: 1–7; median: 2). All sites responded to the 6-month email follow-up which informed maintenance findings. The following sections present assessment results organized by the RE-AIM framework.

Reach

Reach within facilities (the number of people who participated in SPARC intervention activities) varied across sites. The number of staff who participated in the in-person site visit ranged from 5–14 (median: 8).

Facilities engaged staff from up to six departments in their interventions (Table 3). All included pharmacy and unit staff, while some involved staff from administration, intensive care, infection control, information technology (IT), microbiology, nursing, and QI. At least one site engaged individuals from multiple health systems, as providers from several health care systems worked within the facility.

Effectiveness

To assess the effectiveness of SPARC in supporting sites’ intervention activities, sites were asked about support from SPARC as well as the impact their intervention had on outcomes of interest.

Effectiveness of SPARC in supporting the intervention

Most sites valued SPARC’s role in identifying interventions, providing an external perspective on their stewardship program, and workflows related to treatment of suspected sepsis. Several mentioned brainstorming with SPARC, and having additional eyes on their data, helped identify antibiotic stewardship needs and opportunities for intervention on sepsis (eg, opportunities to discontinue antibiotics). Sites also shared office hours were useful for hearing how other facilities implement antibiotic stewardship.

Most sites found learning about different interventions and strategies useful. One small community hospital noted hearing about the challenges SPARC team members face in academic hospital settings was reassuring. However, some shared not all SPARC recommendations were feasible because SPARC team members, affiliated with larger academic hospitals, did not fully understand constraints commonly faced by smaller hospitals.

Sites voiced interest in receiving ongoing SPARC-support, such as continuing intervention office hours or hosting an annual check-in meeting to review progress and realign goals. They also noted SPARC’s role leading advocacy efforts for antibiotic stewardship at the state-level and suggested potential areas where SPARC could be effective (eg, advocating for protected time for pharmacists).

Effectiveness of intervention in creating change

Most sites reported positive changes in stewardship practices due to SPARC support. All sites provided targeted educational activities about appropriate treatment of sepsis for clinical staff through seminars, newsletters, or other media, and a few observed increased knowledge and communication amongst staff. One facility noted the educational activities built and fostered relationships so information could be communicated “through a friendly face.” Another facility highlighted observed changes in provider practices, with providers on the targeted unit “getting the conversation” about de-escalating antibiotics. Several facilities noted improved use of appropriate antibiotics, and one reported reduced broad-spectrum antimicrobial usage. Critically, one site shared leadership agreed to fund a new stewardship pharmacist position.

Changes to sepsis-specific order sets were common, though structures varied due to differences within facilities and different EHRs. While many sites successfully implemented these components, they encountered challenges training providers and encouraging use. One site noted provider uptake of new order sets was low, especially among providers who did not previously use order sets. Another shared providers defaulted to prior order sets due to lack of training on sepsis-specific versions. One site noted, “we were hoping that that would lead to an increase in using the inpatient sepsis order set, and I don’t really think that has happened.”

Adoption

To assess site adoption of SPARC-facilitated recommendations and guidance and site-level adoption of interventions, site participants were asked how insights and recommendations from the team were put into practice within their facilities. As noted above, some sites were not able to adopt recommendations due to resource constraints. Additionally, adoption of interventions was impacted by facility leadership and dynamics between pharmacists and providers.

Role of facility leadership in adoption

Several sites emphasized the importance of leadership support in achieving facility-level intervention adoption. A few noted SPARC’s in-person site visit engaged leadership in stewardship discussions, building shared understanding and securing buy-in. One participant shared, “All my executives, all the way from the providers, everybody, all the executives, were down there at the meeting at that time, [and SPARC] told them exactly, precisely what is needed to be done.”

However, leadership support for the intervention was not universal. One site shared their leadership believed that issues related to antibiotic prescribing and use were due to habits, which they did not believe required large-scale change.

Role of provider acceptance in adoption

Most sites reported general provider support and enthusiasm for the intervention. A few sites noted positive pharmacy perceptions helped promote changes in antibiotic prescribing and highlighted the importance of pharmacist buy-in to promote changes. However, several sites discussed the difficulties pharmacy teams had leading the intervention, and one highlighted some providers were reluctant to accept pharmacists’ recommendations. Other sites shared while providers may be willing to follow pharmacists’ recommendations for specific patients, changing routine clinical practices was challenging.

In some cases, intervention components were adapted to encourage adoption. One site originally planned to include antimicrobial stewardship information related to appropriate sepsis treatment in an internal newsletter, but providers did not regularly read it. To improve uptake, they posted newsletters in the staff break room and near the pneumatic tube system.

Implementation

When asked about their experience implementing the SPARC-supported intervention, sites reported several facilitators (leadership support, structured planning, peer-to-peer learning) and barriers (resource limitations and administrative processes).

Facilitators

Leadership support

Most sites reported having leadership buy-in and noted this was a main facilitator to supporting the implementation of intervention activities. For example, one site reported having actively involved leadership who participated in intervention meetings, revised newsletters, and presented information on the intervention.

Structured planning

Some sites identified the organized, structured, time-bound plan as a key facilitator. One site shared this plan helped secure leadership buy-in and set department priorities by clearly outlining activities to promote antibiotic stewardship and improve outcomes. Another site explained, “if we come up with an intervention that is thoughtful [and] that is logical, the providers understand what we’re doing and we prepare them for the fact that we are going to be intervening on these things, we usually get a very good reception from them.”

Peer-to-peer learning

Several sites found bimonthly office hours helpful for receiving peer support, offering opportunities to share challenges, learn solutions, and discuss strategies. As one site noted, “It was nice to hear that everyone kind of has very similar challenges to us and so that I guess that just hearing everyone else’s experience was helpful and how they’ve dealt with that.”

Barriers

Resources

Several sites emphasized the difficulties of providing training and education with limited pharmacy staff and time. For instance, one site reported while current nurses had received stewardship training, new nurses had not due to pharmacy staffing challenges. They explained, “We don’t have enough staff. We don’t have technicians, so we have pharmacists doing technicians’ jobs. So, we don’t have enough pharmacists to go around to perform all of those things.”

Administrative processes

As each facility developed their own intervention, time lines varied, and most interventions were in progress during the assessment. This was largely due to delays in approvals and implementation of health IT components taking longer than anticipated. One site shared changes to order sets take about a year to implement at their facility. A few participants reported some intervention components were deferred due to limited resources and feasibility. One participant noted, “As we have figured out what may be feasible to focus on, our focus of those interventions has changed… We probably went very big and bold and have realized that that may not be as easy to tackle up [front] or [was] as time sensitive to tackle.” However, most facilities noted that their interventions were “ongoing” and hoped intervention components would become standard and routine.

Several sites highlighted challenges with administrative red tape in large, segmented hospital systems. Challenges included institutional policies, multilayered approval processes, and training requirements. Navigating these internal processes can be slow. One site noted providers from multiple healthcare systems work in their facility, limiting pharmacy’s authority to require training or adherence to order sets.

Maintenance

Maintenance reflects the extent to which changes created by the facility’s SPARC-initiated intervention were sustained over time. Sites noted the need for additional support in accessing and using National Healthcare Safety Network (NHSN) antimicrobial use and resistance data to track progress and secure leadership buy-in. Six months postassessment, all eight sites reported continuing intervention activities: one received approval for their updated sepsis order set, two hired a full-time antibiotic stewardship pharmacist, and others had continued educational activities such as webinars, signs, and newsletters. Multiple sites reported using ongoing tracking and feedback mechanisms to monitor and address inappropriate antibiotic use, and several were in the process of identifying priority antibiotics to track. One site noted they had not yet incorporated duration into order sets due to concerns that doing so might inadvertently extend antibiotic use. Barriers to maintaining momentum included personnel changes and obtaining data needed to track progress.

Discussion

Creating a culture of safety and antibiotic stewardship is a significant challenge for ASPs, which often have a large mission but relatively few resources. 5 While national-level programs can be effective in reducing antibiotic use and educating frontline clinicians about antibiotic stewardship, these programs can be resource-intensive. Reference Tamma, Miller and Dullabh15 Our findings align with other state-based antibiotic stewardship collaboratives illustrating a feasible approach to driving meaningful change and improving stewardship practices in facilities across the state. 16Reference Durant and Guerrazzi-Young18 Common facilitators to improving stewardship practices observed in these collaboratives include opportunities for providing facilities with targeted feedback on prescribing, and peer-to-peer learning. Other state-based antibiotic stewardship collaboratives note similar barriers impacting facilities’ ability to advance antibiotic stewardship such as access to resources and IT support. 16

Effective stewardship requires organizational change and commitment Reference Bankar, Ugemuge, Ambad, Hawale and Timilsina19

Sites valued SPARC’s guidance, noting that an external perspective helped identify and validate issues to generate leadership buy-in. Most reported successes of their interventions, noting gains such as improved communication. Critically, intervention-initiated activities such as education were continuing six months postassessment, indicating a commitment to sustainability.

Collaboration is a key component of antibiotic stewardship

Developing relationships between small programs can foster support, resource sharing, and partnership. Reference Bhatt, Smith, Neuhauser, Srinivasan, Moore and Hyun8 The positive response to office hours highlights the importance of offering touchpoints for ASPs to discuss issues with experts and learn from peers. Collaboration with facilitation is also needed as many face similar barriers, including difficulty changing prescribing culture. A key issue identified by inpatient teams was the continued use of antibiotics for sepsis initiated in the emergency department or by admitting providers. While interventions focused on opportunities to reevaluate antibiotic use after admission through education, communication and order sets, changing prescribing culture is often limited by the culture of non-interference. Reference Charani, Castro-Sanchez and Sevdalis20

Lack of resources may threaten the sustainability of stewardship-focused interventions

All sites highlighted insufficient staff time and funding for dedicated antibiotic stewardship pharmacists as barriers to implementing their interventions. Resource limitation is a well-documented issue for ASPs, Reference Saux, Dalton and Abbass21Reference Wong, Tay and Heng24 and many ASP pharmacists take on significant non-ASP related activities which further reduces capacity for antibiotic stewardship QI interventions. Reference Dionne, Wagner, Chastain, Rosenthal, Mahoney and Bland25

Limitations

This intervention and evaluation have several important limitations. First, we were unable to provide quantitative information about intervention impact due to variability in reporting processes and formats of antibiotic use data across sites. Because participating sites belonged to different health systems there were inconsistencies in types of data available (eg, by specific antimicrobial agents) and the level of granularity (eg, unit-level data), preventing pre and postintervention comparison for specific antibiotics or targeted units. Additionally, there were no consistent metrics that could be compared across sites. As this intervention began in 2023, NHSN AUR reporting was not required, and not all participating sites reported NHSN data during the intervention period. While we were unable to provide quantitative results, these findings reflect real-world settings and offer insights into implementing antibiotic stewardship interventions. Secondly, as sites implemented varied, multi-component interventions, we are unable to identify the contributions of each component. Finally, participation was voluntary and sites who chose to participate may differ from those that did not in resources and leadership support.

Conclusion

Hospitals participating in the SPARC statewide QI project developed tailored sepsis interventions, shared peer-to-peer knowledge, and received targeted guidance to enhance antibiotic stewardship. Our findings highlight that statewide QI collaboratives can promote improved stewardship practices in acute care facilities. Future state-based QI collaboratives should focus on promoting collaboration within facilities to change prescribing culture and managing barriers such as staffing and resources to sustain interventions.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/ash.2026.10296.

Author contribution

All authors contributed to the preparation of this manuscript.

Financial support

This collaborative was supported by the Centers for Disease Control and Prevention (CDC) Epidemiology and Laboratory Capacity funding (CDC grant funding NU50CK000506-02-00).

Competing interests

SMK served on an advisory board for Estasis. All other authors declare no conflicts of interest.

References

Infectious Diseases Society of America (IDSA). Combating antimicrobial resistance: policy recommendations to save lives. Clin Infect Dis 2011;52:S397S428.10.1093/cid/cir153CrossRefGoogle Scholar
Weinberger, J, Rhee, C, Klompas, M. A critical analysis of the literature on time-to-antibiotics in suspected sepsis. J Infect Dis 2020;222:S110S118.10.1093/infdis/jiaa146CrossRefGoogle ScholarPubMed
Fitzpatrick, F, Tarrant, C, Hamilton, V, Kiernan, FM, Jenkins, D, Krockow, EM. Sepsis and antimicrobial stewardship: two sides of the same coin. BMJ Qual Saf 2019;28:758761.10.1136/bmjqs-2019-009445CrossRefGoogle ScholarPubMed
Rhee, C, Chen, T, Kadri, SS, et al. Trends in empiric broad-spectrum antibiotic use for suspected community-onset sepsis in US hospitals. JAMA Netw Open 2024;7:e2418923. doi:10.1001/jamanetworkopen.2024.18923.CrossRefGoogle ScholarPubMed
CDC. Antibiotic Prescribing and Use. Core elements of hospital antibiotic stewardship programs. Accessed October 24, 2024. https://www.cdc.gov/antibiotic-use/hcp/core-elements/hospital.html.Google Scholar
Vaughn, VM, Gupta, A, Petty, LA, et al. A statewide quality initiative to reduce unnecessary antibiotic treatment of asymptomatic bacteriuria. JAMA Intern Med 2023;183:933941.10.1001/jamainternmed.2023.2749CrossRefGoogle ScholarPubMed
Vaughn, VM, Gandhi, TN, Hofer, TP, et al. A statewide collaborative quality initiative to improve antibiotic duration and outcomes in patients hospitalized with uncomplicated community-acquired pneumonia. Clin Infect Dis 2022;75:460467.10.1093/cid/ciab950CrossRefGoogle ScholarPubMed
Bhatt, J, Smith, B, Neuhauser, MM, Srinivasan, A, Moore, P, Hyun, DY. Collaborative solutions to antibiotic stewardship in small community and critical access hospitals. Acad Med 2019;94:1419.10.1097/ACM.0000000000002859CrossRefGoogle ScholarPubMed
Rock, C, Perlmutter, R, Blythe, D, et al. Impact of Statewide Prevention and Reduction of Clostridioides difficile (SPARC), a Maryland public health-academic collaborative: an evaluation of a quality improvement intervention. BMJ Qual Saf 2022;31:153162.10.1136/bmjqs-2021-014014CrossRefGoogle ScholarPubMed
Desai, PJ, Rock, C, Leekha, S, et al. How to support hospitals during the COVID-19 pandemic: lessons from Maryland.Google Scholar
Carroll, AR, Smith, CM, Frazier, SB, Weiner, JG, Johnson, DP. Designing and conducting scholarly quality improvement: a practical guide for improvers everywhere. Hosp Pediatr 2022;12:e359e363.10.1542/hpeds.2022-006717CrossRefGoogle ScholarPubMed
Holtrop, JS, Estabrooks, PA, Gaglio, B, et al. Understanding and applying the RE-AIM framework: clarifications and resources. J Clin Transl Sci 2021;5:e126.10.1017/cts.2021.789CrossRefGoogle ScholarPubMed
Erlingsson, C, Brysiewicz, P. A hands-on guide to doing content analysis. Afr J Emerg Med 2017;7:9399.CrossRefGoogle ScholarPubMed
O’Connor, C, Joffe, H. Intercoder reliability in qualitative research: debates and practical guidelines. Int J Qual Methods 2020;19:1609406919899220.10.1177/1609406919899220CrossRefGoogle Scholar
Tamma, PD, Miller, MA, Dullabh, P, et al. Association of a safety program for improving antibiotic use with antibiotic use and hospital-onset Clostridioides difficile infection rates among US hospitals. JAMA Netw Open 2021;4:e210235.10.1001/jamanetworkopen.2021.0235CrossRefGoogle ScholarPubMed
Pew. Collaboration key to statewide antibiotic stewardship, montana official says. 2022. https://pew.org/3mYsOu3. Accessed July 25, 2025.Google Scholar
Jenkins, TC, Hulett, T, Knepper, BC, et al. A statewide antibiotic stewardship collaborative to improve the diagnosis and treatment of urinary tract and skin and soft tissue infections. Clin Infect Dis 2018;67:15501558.10.1093/cid/ciy268CrossRefGoogle ScholarPubMed
Durant, DJ, Guerrazzi-Young, C. Evaluation of a statewide collaborative focused on antibiotic usage surveillance and stewardship in New York State Hospitals. Am J Infect Control 2023;51:738745.10.1016/j.ajic.2022.11.007CrossRefGoogle ScholarPubMed
Bankar, NJ, Ugemuge, S, Ambad, RS, Hawale, DV, Timilsina, DR. Implementation of antimicrobial stewardship in the healthcare setting. Cureus 2022;14:e26664.Google ScholarPubMed
Charani, E, Castro-Sanchez, E, Sevdalis, N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette.” Clin Infect Dis 2013;57:188196.10.1093/cid/cit212CrossRefGoogle ScholarPubMed
Saux, NL, Dalton, B, Abbass, K, et al. Funding for antimicrobial stewardship programs: a customizable business case template. Can J Hosp Pharm 2018;71:50.Google ScholarPubMed
Nampoothiri, V, Mbamalu, O, Mendelson, M, Singh, S, Charani, E. Pharmacist roles in antimicrobial stewardship: a qualitative study from India, South Africa and the United Kingdom. JAC-Antimicrob Resist 2024;6:dlae047.10.1093/jacamr/dlae047CrossRefGoogle ScholarPubMed
McGregor, JC, Fitzpatrick, MA, Suda, KJ. Expanding antimicrobial stewardship through quality improvement. JAMA Netw Open 2021;4:e211072.10.1001/jamanetworkopen.2021.1072CrossRefGoogle ScholarPubMed
Wong, LH, Tay, E, Heng, ST, et al. Hospital pharmacists and antimicrobial stewardship: a qualitative analysis. Antibiotics 2021;10:1441.10.3390/antibiotics10121441CrossRefGoogle ScholarPubMed
Dionne, B, Wagner, JL, Chastain, DB, Rosenthal, M, Mahoney, MV, Bland, CM. Which pharmacists are performing antimicrobial stewardship: a national survey and a call for collaborative efforts. Antimicrob Steward Healthc Epidemiol ASHE 2022;2:e24.Google Scholar
Figure 0

Table 1. SPARC sepsis intervention components

Figure 1

Table 2. Operationalization of the RE-AIM framework dimensions

Figure 2

Table 3. Facility and intervention characteristics

Supplementary material: File

Karaba et al. supplementary material

Karaba et al. supplementary material
Download Karaba et al. supplementary material(File)
File 185.1 KB